18:48 IST
BSE
Other Announcement
Ind-Swift Laboratories Other Announcement
Ind-Swift Laboratories Ltd has filed its quarterly shareholding pattern as mandated by Regulation 31(1)(c) of the SEBI Listing Regulations.
Ind-Swift Laboratories Ltd
- Share price
- ₹392.50
- Market cap
- ₹3,413 Cr
- Revenue (annual)
- ₹641.3 Cr
- Net profit (annual)
- ₹41.42 Cr
- P/E (TTM)
- 59.5×Sector 47.4×
- Promoter holding
- 42.93%-0.06% QoQ
- FII holding
- 10.90%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 8Capital Structure Change 6Annual General Meeting 6Price Movement Clarification 3Financial Results 3Board Meeting Date 3Employee Stock Options 2Capacity Expansion 2Results Update 1Management Change 1Fund Raise 1Earnings Call 1Board Meeting Outcome 1Annual Report 1
Time
8 announcements with these filters
19:27 IST
NSE
Other Announcement
Ind-Swift Laboratories Other Announcement
Ind-Swift Laboratories Limited submitted a nil statement of deviation or variation for funds raised through its preferential issue of convertible warrants for the quarter ended June 30, 2026.
18:06 IST
BSE
Other Announcement
Ind-Swift Laboratories Other Announcement
Ind-Swift Laboratories Ltd has filed its quarterly shareholding pattern as of June 30, 2026, in compliance with SEBI regulatory requirements.
22:44 IST
NSE
Other Announcement
Ind-Swift Laboratories Other Announcement
Ind-Swift Laboratories has re-appointed M/s. V Kumar & Associates as Cost Auditors for a 12-month term. This routine regulatory compliance ensures continued oversight of the company's cost records.
- Execution
- 12 months
15:43 IST
NSE
Other Announcement
Ind-Swift Laboratories Other Announcement
HCP Investments, a non-promoter entity, sold 6,503,423 equity shares of Ind-Swift Laboratories Limited between April 13 and April 17, 2026. This disposal represents 7.5% of the company's total paid-up share capital. Following the transaction, HCP Investments retains a 1.149% stake in the company.
17:13 IST
BSE
Other Announcement
Ind-Swift Laboratories Other Announcement
HCP Investments, a non-promoter entity, sold 6,503,423 equity shares of Ind-Swift Laboratories Limited via the open market between April 13 and April 17, 2026. This disposal represents 7.5% of the company's paid-up share capital, reducing HCP's holding to 1.149%.
17:25 IST
BSE
Other Announcement
Ind-Swift Laboratories Other Announcement
Ind-Swift Laboratories Ltd received a final arbitration award regarding its dispute with PI Industries Limited. The Arbitral Tribunal rejected all claims and counterclaims from both parties. The proceedings have concluded with nil financial impact on the company, providing legal clarity for investors.
15:25 IST
BSE
Other Announcement
Ind-Swift Laboratories Other Announcement
Ind-Swift Laboratories Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The registrar, Alankit Assignments Ltd, confirmed that physical share certificates received for dematerialization were processed, cancelled, and substituted with the depository's name.
- Execution
- Quarter ended 31st March, 2026